...
首页> 外文期刊>Journal of Tropical Life Science >Antiviral Effect of Pterocarpus indicus Willd Leaves Extract Against Replication of Dengue Virus (DENV) In Vitro
【24h】

Antiviral Effect of Pterocarpus indicus Willd Leaves Extract Against Replication of Dengue Virus (DENV) In Vitro

机译:檀香紫苏叶提取物对登革热病毒(DENV)体外复制的抗病毒作用。

获取原文

摘要

Dengue hemorrhagic fever (DHF) is major public health problem in tropical and subtropical areas of the world with lack of approved vaccines and effective antiviral therapies. With no current treatment for illness attributed to dengue virus (DENV) infection other than supportive care, therapeutic strategies that use natural extract was developed. Indonesia have many plants that potential for antiviral drμgs such as Pterocarpus indicus Willd ( P . indicus ). The objective of this study was to determine the effect of P. indicus to inhibit DENV replication. We used a well-differentiated hepatocytes-derived cellular carcinoma cell line (Huh-7 it-1 cells) to determine and select antiviral activity. The toxicity effects were determined by MTT assay. Then, the suppression of DENV replication was determined by Focus assay. Dengue infected cells with DMSO were used as control. We found that crude extract (Pi), hexane (Pi.1) and ethyl acetate (Pi.2) extract showed strong inhibition with high selectivity index (SI) of 1,392; 285.36 and 168.56 respectively. Sub fraction of Pi.1 and Pi.2 still showed strong inhibition with high SI. Further sub-sub fraction of Pi.2 such as Pi.2.12 and Pi.2.12.1 still showed inhibition of DENV replication but there was reduction of SI value. The mechanism experiment of Pi.2.12, we found that Pi 2.12 more profound to inhibit in the post infection stage that entry or pre-infection. We conclude that the sub-fraction of Pi.2.12 has potential antiviral activity against DV infection in vitro. Further studies are still needed to investigate the pure compound of Pi.2.12 that inhibit and have advantages in the future as alternative for treatment of DENV infection.
机译:登革出血热(DHF)是世界上热带和亚热带地区的主要公共卫生问题,缺乏经过批准的疫苗和有效的抗病毒治疗。除支持治疗外,目前尚无治疗登革热病毒(DENV)感染的疾病的治疗方法,因此开发了使用天然提取物的治疗策略。印度尼西亚有许多潜在的抗病毒药,例如印度檀香木(P. indicus)。这项研究的目的是确定印度假单胞菌抑制DENV复制的作用。我们使用分化良好的肝细胞衍生的细胞癌细胞系(Huh-7 it-1细胞)来确定和选择抗病毒活性。通过MTT试验确定毒性作用。然后,通过聚焦测定法确定DENV复制的抑制。用DMSO感染登革热的细胞用作对照。我们发现粗提取物(Pi),己烷(Pi.1)和乙酸乙酯(Pi.2)提取物显示出较强的抑制作用,并具有1,392的高选择性指数(SI)。分别为285.36和168.56。 Pi.1和Pi.2的子部分仍显示出高SI抑制力。 Pi.2的其他子部分(例如Pi.2.12和Pi.2.12.1)仍然显示出DENV复制的抑制作用,但SI值降低了。通过Pi.2.12的机理实验,我们发现Pi 2.12在感染后阶段抑制进入或感染前更为有效。我们得出结论,Pi.2.12的亚级分具有体外抗DV感染的潜在抗病毒活性。仍然需要进一步的研究来研究Pi.2.12的纯化合物,该化合物在治疗DENV感染方面具有抑制作用,并在将来具有优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号